THURSDAY, July 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer’s drug Leqembi, clearing the way for insurance coverage of the pricey drug. “The full FDA approval will open the floodgates for people with early Alzheimer’s to get this drug.Continue Reading

THURSDAY, July 6, 2023 (HealthDay News) — When frail patients go into cardiac arrest and need cardiopulmonary resuscitation (CPR) during surgery, they’re more likely to die than those who are stronger, a new study shows. Researchers from Brigham and Women’s Hospital in Boston studied the impact of frailty on survivalContinue Reading

MONDAY, July 3, 2023 (HealthDay News) — The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists. Semaglutide (Ozempic, Wegovy) and other drugs of their class known as GLP-1 receptor agonists cause digestionContinue Reading

THURSDAY, June 22, 2023 (HealthDay News) — New York-based physical therapist Brittany Garrett, now 33, was sidelined by excruciating hip pain for close to eight years before she got an accurate diagnosis and effective treatment. She tried physical therapy to improve her flexibility, among other treatments, but nothing seemed toContinue Reading